Financial News
Latest News about MRK
Recent news which mentions MRK
GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial
December 07, 2022
From Benzinga
3 High-Yielding Stocks That Are Up 27%-Plus This Year
December 07, 2022
From Motley Fool
Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today?
December 06, 2022
From InvestorPlace
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
December 06, 2022
From Benzinga
What Bear Market? This Top-Performing Dow Stock Has Thrived in 2022.
December 03, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 29, 2022
From Benzinga
3 Dow Stocks to Take Seriously in 2023
November 29, 2022
From InvestorPlace
Cramer Expects Dow's Outperformance To Last 'Longer' As Traders Chase 'Old-Fashioned, Profitable' Companies Amid Uncertainty
November 29, 2022
From Benzinga
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
November 29, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
From Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 28, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
From Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
November 24, 2022
From InvestorPlace
7 Stocks on the Perfect 10 List
November 23, 2022
From InvestorPlace
Stephen King: Twitter’s only advertiser will soon be MyPillow. Here’s Elon Musk’s response
November 23, 2022
From MarketWatch
Mirati Therapeutics Garners Interest From Large Pharmas Ahead Of Much Awaited Data Next Month
November 23, 2022
From Benzinga
10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients
November 22, 2022
From Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
November 22, 2022
Tickers
MRK
From Benzinga
China’s three-week COVID case tally tops 253,000 and daily average is rising, government says
November 22, 2022
From MarketWatch
First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
November 22, 2022
From Benzinga
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
From Benzinga
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
November 21, 2022
From Motley Fool
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
November 21, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.